Atlas Trials

A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

Clinical trial NCT05690711 · COMPLETED

Trial details

NCT number
NCT05690711
Sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Brain Swelling, Large Hemispheric Infarction
Start date
2023-04-07
Primary completion
2023-12-05
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.